Immunome Cash from Investing (TTM) Analysis

Immunome Inc (IMNM)

13.73 -0.53 (-3.72%) USD | NASDAQ | Apr 26, 16:00

13.72 -0.01 (-0.07%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-30.48M
September 30, 2023	-0.554M
June 30, 2023	-0.518M
March 31, 2023	-0.348M
December 31, 2022	-0.248M
September 30, 2022	-0.19M
June 30, 2022	-0.216M

Date	Value
March 31, 2022	-0.054M
December 31, 2021	-0.079M
September 30, 2021	-0.111M
June 30, 2021	-0.209M
March 31, 2021	-0.562M
December 31, 2020	-0.586M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-30.48M

Minimum

Dec 2023

-0.054M

Maximum

Mar 2022

-2.628M

Average

-0.248M

Median

Dec 2022

Cash from Investing (TTM) Benchmarks